Effects of infliximab on peripheral lymphocyte subsets of patients with active inflammatory bowel disease

医学 溃疡性结肠炎 英夫利昔单抗 内科学 淋巴细胞 胃肠病学 炎症性肠病 CD8型 克罗恩病 免疫学 外周血淋巴细胞 疾病 抗原
作者
Yu Tian,Junxia Li,Yixuan Li,Huahong Wang,Xinguang Liu
出处
期刊:Chinese Journal of Digestion [Chinese Medical Association]
卷期号:34 (01): 41-44
标识
DOI:10.3760/cma.j.issn.0254-1432.2014.01.014
摘要

Objective To investigate the change of the distribution of peripheral blood lymphocyte subsets,before and after treated by infliximab (IFX) in patients with inflammatory bowel disease (IBD).Methods From September 2008 to January 2013,a total of 20 patients with IBD accepted more than three times of IFX treatment and on time follow-up were collected,11 cases of ulcerative colitis (UC) and nine of Crohn's disease (CD).At same time,20 healthy individuals were enrolled as healthy control group.The efficacy of IFX on patients with UC or CD was evaluated according to Mayo score and simplified Crohn's disease active index (CDAI) before and after treatment.Fasting blood of healthy control group,one day before IFX treatment and in 24 to 72 hours after the third time of IFX injection of IBD patients was collected.The percentage of total T lymphocyte,total B lymphocyte,CD4+ T lymphocyte,CD8+ T lymphocyte and natural killer (NK) cell in lymphocyte was determined by fluorescent labeled monoclonal antibodies and flow cytometry.Independent sample t-test was performed for comparison between two groups.Analysis of variance was for comparison among three groups.Results Three of 11 patients with UC achieved clinical remission,three cases were clinical improved and five cases were ineffectiveness.Among nine CD patients,one achieved clinical remission,six cases were clinical improved and two cases were ineffectiveness.Of UC patients,the percentage of total T lymphocyte before and after treatment ((84.2±8.1) % and (82.1±6.2)%),the percentage of CD8+ T lymphocyte before treatment ((40.0± 13.2)%) were all higher than that of healthy control group ((74.7±10.7)% and (30.5±11.9) %),while the percentage of NK cell before and after treatment ((5.1±2.8)% and (7.8±4.3)%) were all lower than that of healthy control group ((13.7 ±7.8)%) and the differences were statistically significant (t=2.540,2.074,2.251,3.464 and 2.063,all P<0.05).Compared with healthy controls,there were no significant differences in the percentage of total B lymphocyte and CD4+ T lymphocyte of UC patients before and after treatment,the percentage of total T lymphocyte,total B lymphocyte,CD4+ T lymphocyte,CD8+T lymphocyte and NK cell of CD patients before and after treatment (all P>0.05).Before treatment,there were significant differences among effective treatment group,ineffective treatment group and healthy control group in the percentage of total T lymphocyte,CD8+ T lymphocyte and NK cell (F=4.095,4.571 and 7.432,all P<0.05),of those there were significant differences between ineffective treatment group ((88.3 ± 8.2) %,(44.4 ± 11.5) % and (4.6 ± 3.2) %) and healthy control group (t=2.902,2.105 and 3.647,all P<0.05).Conclusion The percentage of peripheral blood total T lymphocyte and CD8+T lymphocyte increase in active IBD patients with ineffective IFX treatment,however the percentage of NK cell decreases. Key words: Inflammatory bowel diseases;  Lymphocyte subsets;  Antibodies, monoclonal;  Drug therapy
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Dr.Lee发布了新的文献求助10
刚刚
搜集达人的应助被逢坂大河采纳,获得10
1秒前
1秒前
呼呀呼发布了新的文献求助10
1秒前
郑睿涛发布了新的文献求助10
3秒前
3秒前
4秒前
d5hh的应助被高兴的彩虹采纳,获得10
4秒前
5秒前
7秒前
lzh关闭了lzh的文献求助
7秒前
斯旅未央发布了新的文献求助10
7秒前
8秒前
111发布了新的文献求助10
8秒前
科科比完成签到,获得积分10
9秒前
ww完成签到,获得积分20
9秒前
李麟发布了新的文献求助10
9秒前
9秒前
小y同学发布了新的文献求助10
9秒前
可爱的函函的应助被tourist585采纳,获得10
10秒前
sun完成签到,获得积分10
10秒前
思源的应助被宿宿采纳,获得10
11秒前
科研通AI65的应助被超级的之卉采纳,获得10
11秒前
乐乐的应助被叫你吃布丁采纳,获得10
11秒前
NexusExplorer的应助被呼呀呼采纳,获得10
12秒前
12秒前
逢坂大河发布了新的文献求助10
12秒前
19826536343完成签到,获得积分10
12秒前
体贴千山完成签到,获得积分10
13秒前
子岚发布了新的文献求助10
13秒前
卡卡完成签到,获得积分10
13秒前
爱科研的赛的应助被牧百川采纳,获得10
14秒前
李xxxx完成签到 ,获得积分10
15秒前
Dr.Lee完成签到,获得积分10
15秒前
lyla发布了新的文献求助10
15秒前
祈愿完成签到 ,获得积分10
15秒前
文静的怜烟完成签到,获得积分10
16秒前
16秒前
NexusExplorer的应助被Prunier采纳,获得10
16秒前
TaoJ的应助被虚心的凡霜采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183730
求助须知:如何正确求助?哪些是违规求助? 9572975
关于积分的说明 21828453
捐赠科研通 7780887
什么是DOI,文献DOI怎么找? 3434086
关于科研通互助平台的介绍 2558276
邀请新用户注册赠送积分活动 2480557